Retracted: Verifying the Usefulness of Pulmonary Blood Flow Studies in the Correction of Pulmonary Atresia and Ventricular Septal Defect with Major Aortopulmonary Collateral Arteries
Cardiol Res Pract. 2023 Oct 11;2023:9860567. doi: 10.1155/2023/9860567. eCollection 2023.ABSTRACT[This retracts the article DOI: 10.1155/2021/3483976.].PMID:37868165 | PMC:PMC10586337 | DOI:10.1155/2023/9860567 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - October 23, 2023 Category: Cardiology Authors: Cardiology Research And Practice Source Type: research
Serum Galectin-3 Predicts Mortality in Venoarterial Extracorporeal Membrane Oxygenation Patients
CONCLUSION: Gal-3 may serve as a prognostic indicator for patients receiving VA-ECMO for cardiogenic shock. The combined early warning score is a simple and effective tool for predicting mortality in VA-ECMO patients.PMID:37810435 | PMC:PMC10560122 | DOI:10.1155/2023/3917156 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - October 9, 2023 Category: Cardiology Authors: Jianlong Zhu Dehui Guo Liying Liu Jing Zhong Source Type: research
Serum Galectin-3 Predicts Mortality in Venoarterial Extracorporeal Membrane Oxygenation Patients
CONCLUSION: Gal-3 may serve as a prognostic indicator for patients receiving VA-ECMO for cardiogenic shock. The combined early warning score is a simple and effective tool for predicting mortality in VA-ECMO patients.PMID:37810435 | PMC:PMC10560122 | DOI:10.1155/2023/3917156 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - October 9, 2023 Category: Cardiology Authors: Jianlong Zhu Dehui Guo Liying Liu Jing Zhong Source Type: research
Serum Galectin-3 Predicts Mortality in Venoarterial Extracorporeal Membrane Oxygenation Patients
CONCLUSION: Gal-3 may serve as a prognostic indicator for patients receiving VA-ECMO for cardiogenic shock. The combined early warning score is a simple and effective tool for predicting mortality in VA-ECMO patients.PMID:37810435 | PMC:PMC10560122 | DOI:10.1155/2023/3917156 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - October 9, 2023 Category: Cardiology Authors: Jianlong Zhu Dehui Guo Liying Liu Jing Zhong Source Type: research
Serum Galectin-3 Predicts Mortality in Venoarterial Extracorporeal Membrane Oxygenation Patients
CONCLUSION: Gal-3 may serve as a prognostic indicator for patients receiving VA-ECMO for cardiogenic shock. The combined early warning score is a simple and effective tool for predicting mortality in VA-ECMO patients.PMID:37810435 | PMC:PMC10560122 | DOI:10.1155/2023/3917156 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - October 9, 2023 Category: Cardiology Authors: Jianlong Zhu Dehui Guo Liying Liu Jing Zhong Source Type: research
Serum Galectin-3 Predicts Mortality in Venoarterial Extracorporeal Membrane Oxygenation Patients
CONCLUSION: Gal-3 may serve as a prognostic indicator for patients receiving VA-ECMO for cardiogenic shock. The combined early warning score is a simple and effective tool for predicting mortality in VA-ECMO patients.PMID:37810435 | PMC:PMC10560122 | DOI:10.1155/2023/3917156 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - October 9, 2023 Category: Cardiology Authors: Jianlong Zhu Dehui Guo Liying Liu Jing Zhong Source Type: research
Serum Galectin-3 Predicts Mortality in Venoarterial Extracorporeal Membrane Oxygenation Patients
CONCLUSION: Gal-3 may serve as a prognostic indicator for patients receiving VA-ECMO for cardiogenic shock. The combined early warning score is a simple and effective tool for predicting mortality in VA-ECMO patients.PMID:37810435 | PMC:PMC10560122 | DOI:10.1155/2023/3917156 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - October 9, 2023 Category: Cardiology Authors: Jianlong Zhu Dehui Guo Liying Liu Jing Zhong Source Type: research
Serum Galectin-3 Predicts Mortality in Venoarterial Extracorporeal Membrane Oxygenation Patients
CONCLUSION: Gal-3 may serve as a prognostic indicator for patients receiving VA-ECMO for cardiogenic shock. The combined early warning score is a simple and effective tool for predicting mortality in VA-ECMO patients.PMID:37810435 | PMC:PMC10560122 | DOI:10.1155/2023/3917156 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - October 9, 2023 Category: Cardiology Authors: Jianlong Zhu Dehui Guo Liying Liu Jing Zhong Source Type: research
Serum Galectin-3 Predicts Mortality in Venoarterial Extracorporeal Membrane Oxygenation Patients
CONCLUSION: Gal-3 may serve as a prognostic indicator for patients receiving VA-ECMO for cardiogenic shock. The combined early warning score is a simple and effective tool for predicting mortality in VA-ECMO patients.PMID:37810435 | PMC:PMC10560122 | DOI:10.1155/2023/3917156 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - October 9, 2023 Category: Cardiology Authors: Jianlong Zhu Dehui Guo Liying Liu Jing Zhong Source Type: research
Serum Galectin-3 Predicts Mortality in Venoarterial Extracorporeal Membrane Oxygenation Patients
CONCLUSION: Gal-3 may serve as a prognostic indicator for patients receiving VA-ECMO for cardiogenic shock. The combined early warning score is a simple and effective tool for predicting mortality in VA-ECMO patients.PMID:37810435 | PMC:PMC10560122 | DOI:10.1155/2023/3917156 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - October 9, 2023 Category: Cardiology Authors: Jianlong Zhu Dehui Guo Liying Liu Jing Zhong Source Type: research
Serum Galectin-3 Predicts Mortality in Venoarterial Extracorporeal Membrane Oxygenation Patients
CONCLUSION: Gal-3 may serve as a prognostic indicator for patients receiving VA-ECMO for cardiogenic shock. The combined early warning score is a simple and effective tool for predicting mortality in VA-ECMO patients.PMID:37810435 | PMC:PMC10560122 | DOI:10.1155/2023/3917156 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - October 9, 2023 Category: Cardiology Authors: Jianlong Zhu Dehui Guo Liying Liu Jing Zhong Source Type: research
Serum Galectin-3 Predicts Mortality in Venoarterial Extracorporeal Membrane Oxygenation Patients
CONCLUSION: Gal-3 may serve as a prognostic indicator for patients receiving VA-ECMO for cardiogenic shock. The combined early warning score is a simple and effective tool for predicting mortality in VA-ECMO patients.PMID:37810435 | PMC:PMC10560122 | DOI:10.1155/2023/3917156 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - October 9, 2023 Category: Cardiology Authors: Jianlong Zhu Dehui Guo Liying Liu Jing Zhong Source Type: research
Retracted: Clinical Study on Long-Term Sinus Reversion Rate and Left Atrial Function Recovery of Mitral Valve Disease with Atrial Fibrillation under Modified Surgical Radiofrequency Ablation
Cardiol Res Pract. 2023 Aug 16;2023:9820581. doi: 10.1155/2023/9820581. eCollection 2023.ABSTRACT[This retracts the article DOI: 10.1155/2021/5667364.].PMID:37621308 | PMC:PMC10447015 | DOI:10.1155/2023/9820581 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - August 25, 2023 Category: Cardiology Authors: Cardiology Research And Practice Source Type: research
Retracted: The Long-Term Change of Arrhythmias after Transcatheter Closure of Perimembranous Ventricular Septal Defects
Cardiol Res Pract. 2023 Aug 16;2023:9898161. doi: 10.1155/2023/9898161. eCollection 2023.ABSTRACT[This retracts the article DOI: 10.1155/2021/1625915.].PMID:37621309 | PMC:PMC10447158 | DOI:10.1155/2023/9898161 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - August 25, 2023 Category: Cardiology Authors: Cardiology Research And Practice Source Type: research
Retracted: Clinical Study on Long-Term Sinus Reversion Rate and Left Atrial Function Recovery of Mitral Valve Disease with Atrial Fibrillation under Modified Surgical Radiofrequency Ablation
Cardiol Res Pract. 2023 Aug 16;2023:9820581. doi: 10.1155/2023/9820581. eCollection 2023.ABSTRACT[This retracts the article DOI: 10.1155/2021/5667364.].PMID:37621308 | PMC:PMC10447015 | DOI:10.1155/2023/9820581 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - August 25, 2023 Category: Cardiology Authors: Cardiology Research And Practice Source Type: research
